Insider Trading › DBVT › Insiders
DBV Technologies S.A.
DBVT·Nasdaq·Insider activity
$9.98
-0.46 (-4.41%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
DBVT
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
DBVTS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, DBVT insiders filed 0 purchases ($0) and 1 sale ($0) on the open market, by 1 insider. Newest filing Jul 31, 2026 (2 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by DBVT insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$0Sales · 180 days
23Open-market transactions on record
1Insiders filing · 180 days
Purchases (code P) and sales (code S) of DBVT common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
23 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Mohideen PharisChief Medical Officer | Sale | −464 | n/c | — | 144.5Kdirect | Jul 29, 2026 | Jul 31, 2026 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −534 | n/c | — | 145.0Kdirect | Jan 29, 2026 | Feb 2, 2026 | Form 4 ↗ |
| EPIC Bpifrance | Sale | −1.3M | n/c | — | 7.3Mindirect | Dec 18, 2025 | Dec 19, 2025 | Form 4 ↗ |
| EPIC Bpifrance | Sale | −40.0K | n/c | — | 8.6Mindirect | Dec 17, 2025 | Dec 19, 2025 | Form 4 ↗ |
| EPIC Bpifrance | Sale | −2.0M | n/c | — | 8.6Mindirect | Dec 17, 2025 | Dec 19, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −1,624 | n/c | — | 101.5Kdirect | Nov 21, 2025 | Nov 25, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −6,496 | n/c | — | 103.2Kdirect | Nov 20, 2025 | Nov 25, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −464 | n/c | — | 109.6Kdirect | Jul 29, 2025 | Jul 31, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −397 | n/c | — | 110.1Kdirect | May 22, 2025 | May 27, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −600 | n/c | — | 110.5Kdirect | Jan 30, 2025 | Jan 31, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −565 | $0.57 | $322 | 111.1Kdirect | Nov 25, 2024 | Nov 27, 2024 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −342 | $0.53 | $181 | 111.7Kdirect | Nov 22, 2024 | Nov 27, 2024 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −2,350 | $0.54 | $1K | 112.0Kdirect | Nov 21, 2024 | Nov 25, 2024 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −1,785 | $0.98 | $2K | 79.4Kdirect | Jul 29, 2024 | Jul 31, 2024 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −660 | n/c | — | 81.2Kdirect | May 24, 2024 | May 29, 2024 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −382 | n/c | — | 81.8Kdirect | May 22, 2024 | May 29, 2024 | Form 4 ↗ |
| Tasse DanielCHIEF EXECUTIVE OFFICER · Director | Purchase | +17.1K | $0.83 | $14K | 17.1Kdirect | Mar 8, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Ndu AdoraDirector | Purchase | +1,825 | $0.89 | $2K | 1,825direct | Feb 6, 2024 | Feb 8, 2024 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −2,245 | n/c | — | 82.2Kdirect | Nov 22, 2023 | Dec 19, 2023 | Form 4 ↗ |
| MORRIS TIMOTHY EDirector | Purchase | +12.0K | $1.52 | $18K | 12.0Kdirect | Aug 25, 2023 | Aug 28, 2023 | Form 4 ↗ |
| SOLAND DANIEL BDirector | Purchase | +15.0K | $1.62 | $24K | 20.0Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −469 | n/c | — | 49.4Kdirect | May 24, 2023 | Aug 14, 2023 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −1,792 | $2.88 | $5K | 49.9Kdirect | Nov 24, 2022 | Aug 14, 2023 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →